Cullinan Therapeutics, Inc.
CGEM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $83,005 | $98,434 | $156,152 | $59,774 |
| Short-Term Investments | $315,972 | $368,633 | $311,140 | $230,692 |
| Receivables | $3,000 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $12,691 | $13,124 | $7,180 | $6,098 |
| Total Curr. Assets | $414,668 | $480,191 | $474,472 | $296,564 |
| Property Plant & Equip (Net) | $2,350 | $3,532 | $5,304 | $77 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $204,440 | $0 | $80,882 | $140,397 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $366 | $459 | $459 | $147 |
| Total NC Assets | $207,156 | $3,991 | $86,645 | $140,621 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $621,824 | $484,182 | $561,117 | $437,185 |
| Liabilities | – | – | – | – |
| Payables | $1,682 | $2,493 | $2,660 | $3,169 |
| Short-Term Debt | $1,302 | $1,440 | $1,599 | $0 |
| Tax Payable | $0 | $0 | $4,282 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27,663 | $24,204 | $13,957 | $8,577 |
| Total Curr. Liab. | $30,647 | $28,137 | $22,498 | $11,746 |
| LT Debt | $849 | $2,150 | $3,590 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $65 |
| Total NC Liab. | $849 | $2,150 | $3,590 | $65 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,151 | $3,590 | $5,011 | $0 |
| Total Liabilities | $31,496 | $30,287 | $26,088 | $11,811 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $4 | $5 | $4 |
| Retained Earnings | -$368,240 | -$200,857 | -$47,695 | -$158,909 |
| AOCI | -$133 | -$129 | -$2,601 | -$838 |
| Other Equity | $958,695 | $654,685 | $585,320 | $584,714 |
| Total Equity | $590,328 | $453,703 | $535,029 | $424,971 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $192 | $0 | $403 |
| Total Liab. & Tot. Equity | $621,824 | $484,182 | $561,117 | $437,185 |
| Net Debt | -$80,854 | -$94,844 | -$150,963 | -$59,774 |